DNA Synthesis Market Accelerates on Precision Medicine, Synthetic Biology and High-Throughput Automation Demand
Dublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "DNA Synthesis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com'soffering.
Global DNA Synthesis Market to Reach USD 11.5 Billion by 2035, Driven by Synthetic Biology and Precision Medicine
The global DNA synthesis market, valued at USD 2.5 billion in 2025, is projected to reach USD 11.5 billion by 2035, expanding at a compound annual growth rate (CAGR) of 16.3%. Market growth is being driven by rising demand for synthetic DNA in molecular biology, genetic engineering, synthetic biology, clinical diagnostics, drug discovery, vaccine development, and personalized medicine.
Increasing rates of genetic and chronic diseases are encouraging pharmaceutical companies, biotechnology firms, and research institutions to accelerate genomics research and develop next-generation therapeutic solutions. Greater investment in biotechnology, wider adoption of high-throughput DNA synthesis platforms, and continued advancements in genomic technologies are also supporting global market expansion.
Automation and digitalization are transforming DNA synthesis workflows by improving scalability, speed, accuracy, and cost efficiency. Advanced commercial synthesis services are making customized genetic material more accessible to academic laboratories, pharmaceutical developers, contract research organizations, and synthetic biology companies. Strategic collaborations across the life sciences sector are further expanding the use of DNA-based tools in precision medicine, engineered biological systems, molecular diagnostics, gene editing, and therapeutic development.
Oligonucleotide Synthesis Segment Maintains Strong Growth
The oligonucleotide synthesis segment is forecast to grow at a CAGR of 16% from 2026 to 2035. Growth is supported by extensive use in polymerase chain reaction (PCR), quantitative PCR, gene sequencing, cloning, molecular diagnostics, and gene-editing applications. Oligonucleotides remain essential laboratory consumables across clinical and research settings, generating consistent and recurring demand.
Product innovation, improved synthesis technologies, and strategic partnerships among DNA synthesis companies are expected to strengthen the segment further. Manufacturers are investing in high-throughput platforms and quality-control systems that enable faster production, greater sequence accuracy, and more efficient delivery of customized products.
Academic and Research Institutes Lead End-User Demand
Academic and research institutes accounted for 54.5% of the global DNA synthesis market in 2025. The segment's leadership reflects widespread adoption of synthetic DNA in genomics, molecular cloning, functional biology, pathway engineering, and other life sciences research.
Ongoing public and private funding for universities, government laboratories, and specialized research centers continues to support demand for oligonucleotide and gene synthesis services. Increased collaboration between academic institutions and commercial biotechnology organizations is also helping translate scientific discoveries into diagnostic, pharmaceutical, and industrial applications.
North America Holds the Largest Regional Market Share
North America represented 38.7% of the DNA synthesis market in 2025. The region benefits from substantial biotechnology and genomics investments, advanced research infrastructure, strong government support, and the presence of leading DNA synthesis providers.
A mature life sciences ecosystem comprising pharmaceutical companies, synthetic biology developers, contract research organizations, and academic institutions is accelerating the adoption of high-throughput DNA synthesis technologies. Partnerships between industry participants and research organizations are also advancing drug discovery, vaccine research, precision medicine, and other genomics-driven applications across the region.
Competitive Landscape and Corporate Strategies
Prominent companies operating in the global DNA synthesis industry include GenScript Biotech, Thermo Fisher Scientific, Eurofins Scientific, Integrated DNA Technologies, Twist Bioscience, BIOMATIK, Bioneer, Eton Bioscience, IBA Lifesciences, Kaneka Eurogentec, LGC Biosearch Technologies, OriGene Technologies, ProMab Biotechnologies, ProteoGenix, Quintara Biosciences, Shenzhen Shuxin Biotechnology, and Synbio Technologies.
Market participants are prioritizing technological innovation, automation, production scalability, and high-throughput synthesis capabilities. Investments in next-generation platforms are focused on improving synthesis speed, sequence accuracy, cost efficiency, and customization. Companies are also broadening their service portfolios, strengthening global distribution networks, and introducing rapid-delivery solutions to address growing demand from pharmaceutical, biotechnology, clinical, and academic customers.
Strategic collaborations with pharmaceutical companies, biotechnology developers, and research institutes remain central to competitive growth. These partnerships are supporting product development, expanding application reach, and accelerating the commercialization of advanced genetic technologies.
Comprehensive Market Analysis and Forecast
-
DNA synthesis industry trends, growth drivers, market challenges, future opportunities, and regulatory developments
-
Competitive landscape assessment, including Porter's Five Forces and PESTEL analysis
-
Global market size, segment performance, and regional forecasts through 2035
-
Detailed company profiles, business strategies, financial insights, and SWOT analysis
The global DNA synthesis market is positioned for sustained expansion as precision medicine, synthetic biology, genomics, and engineered biological systems become increasingly important across healthcare and life sciences. Continued advances in automation, synthesis technologies, and collaborative research are expected to create significant opportunities for established companies and emerging market participants through 2035.
Key Attributes:
| Report Attribute |
Details |
|---|---|
| No. of Pages |
135 |
| Forecast Period |
2025 - 2035 |
| Estimated Market Value (USD) in 2025 |
$2.5 Billion |
| Forecasted Market Value (USD) by 2035 |
$11.5 Billion |
| Compound Annual Growth Rate |
16.3% |
| Regions Covered |
Global |
Key Topics Covered:
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research approach
1.3 Quality commitments
1.3.1 GMI AI policy and data integrity commitment
1.3.1.1 Source consistency protocol
1.4 Research trail and confidence scoring
1.4.1 Research trail components
1.4.2 Scoring components
1.5 Data collection
1.5.1 Partial list of primary sources
1.6 Data mining sources
1.6.1 Paid sources
1.6.1.1 Sources, by region
1.7 Base estimates and calculations
1.7.1 Revenue share analysis
1.7.2 Base year calculation
1.8 Forecast model
1.9 Research transparency addendum
1.9.1 Source attribution framework
1.9.2 Quality assurance metrics
1.9.3 Our commitment to trust
Chapter 2 Executive Summary
2.1 Industry 360o synopsis
2.1.1 Regional trends
2.1.2 Service trends
2.1.3 Method trends
2.1.4 Application trends
2.1.5 End Use trends
2.2 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of diseases globally
3.2.1.2 Rapid technology advancements in the field of synthetic biology
3.2.1.3 Rising investments towards research and development(R&D) activities
3.2.2 Industry pitfalls and challenges
3.2.2.1 Stringent government regulations and guidelines
3.2.2.2 High cost, potential biosafety,biosecurity and ethical issues
3.2.3 Market opportunities
3.2.3.1 Advancement of enzymatic and cell-free DNA synthesis technologies
3.2.3.2 Expansion of DNA data storage commercialization opportunities
3.3 Growth potential analysis
3.4 Regulatory landscape (Driven by Primary Research)
3.4.1 North America
3.4.2 Europe
3.4.3 Asia-Pacific
3.4.4 Latin America
3.4.5 MEA
3.5 Technology landscape
3.5.1 Current technological trends
3.5.1.1 Automation and high-throughput DNA synthesis platforms
3.5.1.2 Advancements in enzymatic DNA synthesis
3.5.2 Emerging technologies
3.5.2.1 Integration with cell-free and cell-based manufacturing systems
3.5.2.2 Cloud-based DNA synthesis platforms and digital labs
3.6 Future market trends (Driven by Primary Research)
3.7 Impact of AI and Generative AI on the market (Driven by Primary Research)
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2025
4.1 Introduction
4.2 Company market share analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia-Pacific
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
4.6.1 Merger and acquisition
4.6.2 Partnership and collaboration
4.6.3 New product launches
4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, by Service, 2022-2035 ($ Mn)
5.1 Key trends
5.2 Oligonucleotide synthesis
5.2.1 Standard oligonucleotide synthesis
5.2.2 Custom oligonucleotide synthesis
5.3 Gene Synthesis
5.3.1 Custom gene synthesis
5.3.2 Gene library synthesis
Chapter 6 Market Estimates and Forecast, by Method, 2022-2035 ($ Mn)
6.1 Key trends
6.2 Solid phase synthesis
6.3 PCR-based enzyme synthesis
6.4 CHIP-based DNA synthesis
Chapter 7 DNA Synthesis Market Size and Forecast, by Application, 2022-2035 ($ Mn)
7.1 Key trends
7.2 Research and development
7.3 Diagnostics
7.4 Therapeutics
Chapter 8 DNA Synthesis Market Size and Forecast, by End Use, 2022-2035 ($ Mn)
8.1 Key trends
8.2 Academic and research institutes
8.3 Contract research organizations
8.4 Biopharmaceutical companies
Chapter 9 DNA Synthesis Market Size and Forecast, by Region, 2022-2035 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 BIOMATIK
10.2 Bioneer
10.3 Eton Bioscience
10.4 Eurofins Scientific
10.5 GenScript Biotech
10.6 IBA Lifesciences
10.7 Integrated DNA Technologies
10.8 Kaneka Eurogentec
10.9 LGC Biosearch Technologies
10.10 OriGene Technologies
10.11 ProMab Biotechnologies
10.12 ProteoGenix
10.13 Quintara Biosciences
10.14 Shenzhen Shuxin Biotechnology
10.15 Synbio Technologies
10.16 Thermo Fisher Scientific
10.17 Twist Bioscience
For more information about this report visit https://www.researchandmarkets.com/r/2ltztw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
